CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Sep. 30, 2022	Dec. 31, 2021
Current assets
Cash	$ 77,461	$ 26,766
Accounts receivable, net	7,635	5,231
Inventory, net	10,181	9,615
Other current assets	5,534	5,473
Total current assets	100,811	47,085
Property and equipment, net	1,776	2,335
Capitalized software, net	5,118	4,554
Operating lease right-of-use assets	181	356
Deferred tax asset	1,692
Total assets	109,578	54,330
Current liabilities
Accounts payable	8,245	4,349
Accrued expenses	5,719	6,011
Term loan, current	6,250	5,000
Deferred revenue, current	1,989	1,705
Operating lease liabilities, current	190	248
Total current liabilities	22,393	17,313
Term loan, net of current portion	113,451	31,963
Deferred revenue, net of current portion	862	802
Operating lease liabilities, net of current portion		127
Warrant liability	4,679
Earnout liability	39,040
Total liabilities	180,425	50,205
Commitments and contingencies (See Note 18)
Stockholders' Equity (Deficit)
Preferred stock, $0.0001 par value, 10,000,000 shares authorized; no shares issued or outstanding
Additional Paid in Capital	0	0
Retained earnings (Accumulated deficit)	(48,119)	4,165
Accumulated other comprehensive loss	(6)	(40)
biote Corp.'s stockholders' equity (deficit)	(48,119)	4,125
Noncontrolling interest	(22,728)
Total stockholders' equity (deficit)	(70,847)	4,125
Total liabilities and stockholders' equity (deficit)	109,578	54,330
Class A Common Stock
Stockholders' Equity (Deficit)
Common stock value	1
Class B Common Stock
Stockholders' Equity (Deficit)
Common stock value	0	$ 0
Class V Common Stock
Stockholders' Equity (Deficit)
Common stock value	$ 5